Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
N,N-[2,5-O-dibenzyl-glucaryl]-DI-[valinyl-aminomethanyl-pyridine]
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
N,N-[2,5-O-dibenzyl-glucaryl]-DI-[valinyl-aminomethanyl-pyridine] is an experimental small molecule inhibitor, also known as INHIBITOR MSA367 and MS3. It is a synthetic compound classified as an amino acid derivative and peptide analog. The molecule features a glucaric acid core with dibenzyl protection at the 2 and 5 positions, linked via amide bonds to two valine-derived aminomethanyl-pyridine moieties. Its primary research use has been as a chemical inhibitor in structural biology studies; it has not been approved for clinical use or assigned any therapeutic indication. There are no reported clinical trials or marketed products containing this compound[1][6][8]. Its mechanism of action is not explicitly described in public sources, but it has been used in the context of HIV Gag-Pol polyprotein inhibition studies[3].
- Other names
- MS3MS-3MS 3
02
Targets
PR (Progesterone receptor)
Beyond the preview
Go deeper on N,N-[2,5-O-dibenzyl-glucaryl]-DI-[valinyl-aminomethanyl-pyridine].
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on N,N-[2,5-O-dibenzyl-glucaryl]-DI-[valinyl-aminomethanyl-pyridine].